Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stat6(null phenotype) human lymphocytes exhibit increased apoptosis.

Eva Galka1, Jennifer Lynn Thompson, Wen Jie Zhang

  • 1Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center, Section of Colon and Rectal Surgery, MCH137, Hershey, Pennsylvania, USA. egalka@psu.edu

The Journal of Surgical Research
|November 4, 2004
PubMed
Summary

Dysfunctional Stat6 (Signal Transducer and Activator of Transcription 6) is linked to increased apoptosis in inflammatory bowel disease (IBD) cell lines. This apoptosis is not caused by elevated Th1 cytokines like IL-12 and IFN-gamma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative host transcriptomic and mucosal microbiome profiling reveals region-specific host-microbiome associations across the human intestine.

bioRxiv : the preprint server for biology·2026
Same author

Time-resolved reprogramming of single somatic cells into totipotent states during plant regeneration.

Cell·2025
Same author

Time-resolved reprogramming of single somatic cells into totipotent states during plant regeneration.

Cell·2025
Same author

Loss of STIM2, but not of STIM1, drives colorectal cancer metastasis through metabolic reprogramming and the ATF4 ER stress pathway.

Science signaling·2025
Same author

Apixaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis in Colorectal Surgery.

The Journal of surgical research·2025
Same author

Twenty Years of Disease-Modifying Anti-IBD Drug Use Preceding Colectomy for Refractory IBD-Associated Colitis.

Diseases of the colon and rectum·2025

Area of Science:

  • Immunology
  • Molecular Biology
  • Gastroenterology

Background:

  • Inflammatory bowel disease (IBD) is characterized by altered apoptosis and elevated Th1 cytokines.
  • Dysfunctional IL-4/Stat6 signaling may contribute to IBD pathogenesis by impairing Th2 differentiation.
  • Stat6 plays a crucial role in regulating immune responses and lymphocyte differentiation.

Purpose of the Study:

  • To investigate apoptosis levels in IBD-derived cell lines with dysfunctional (Stat6-null) versus wild-type (Stat6-high) Stat6.
  • To measure cytokine profiles (IL-12, TNF-alpha, IFN-gamma) in these cell lines.
  • To determine the impact of cytokine manipulation on apoptosis in Stat6-null cells.

Main Methods:

  • Cultured lymphocytes from IBD patients with Stat6-null or wild-type status.

Related Experiment Videos

  • Assessed apoptosis using Annexin V-PE staining via flow cytometry.
  • Quantified cytokine levels using ELISA and manipulated cytokine concentrations.

    • Main Results:

    • Stat6-null cells showed significantly higher apoptosis rates (13.3%) compared to wild-type cells (4.5%).
    • Four of five Stat6-null cell lines exhibited 5- to 10-fold increases in IL-12 and IFN-gamma.
    • Exogenous cytokines or neutralizing antibodies did not alter apoptosis levels in Stat6-null cells.

    Conclusions:

    • Elevated apoptosis in Stat6-null cells suggests a novel role for Stat6 in apoptosis regulation.
    • Increased Th1 cytokines (IL-12, IFN-gamma) in Stat6-null cells are not the direct cause of observed apoptosis.
    • Stat6-null cell lines offer a valuable model for studying IBD pathophysiology and immune dysregulation.